• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对92例室管膜瘤患儿的回顾性分析:意大利儿科神经肿瘤学组

Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.

作者信息

Perilongo G, Massimino M, Sotti G, Belfontali T, Masiero L, Rigobello L, Garrè L, Carli M, Lombardi F, Solero C, Sainati L, Canale V, del Prever A B, Giangaspero F, Andreussi L, Mazza C, Madon E

机构信息

Pediatric Oncology Division-Pediatric Department, University of Padova, Italy.

出版信息

Med Pediatr Oncol. 1997 Aug;29(2):79-85. doi: 10.1002/(sici)1096-911x(199708)29:2<79::aid-mpo3>3.0.co;2-o.

DOI:10.1002/(sici)1096-911x(199708)29:2<79::aid-mpo3>3.0.co;2-o
PMID:9180907
Abstract

The principal aim of this report is to present the results of multivariate analyses conducted to identify clinical prognostic factors in 92 children aged < 16 years with ependymoma (EPD) retrospectively collected in seven Italian centres. They were treated over a 16-year period (1977-1993). Treatment modalities varied. Surgery and radiotherapy (RT) was the "gold standard" management method for the majority of these children. Only in the late 1980s did some of them receive chemotherapy (CT), mainly with vincristine, lomustine (CCNU) and prednisone. The median follow-up of the entire study population is 36 months (average 43 months; range 12 to 214 months). The 10-year overall (OS) and the progression-free survival (PFS) of the study population were 55.5% (CI 41.4-69.4%) and 34.7% (CI 21.4-47.8%), respectively. Age (< 5 years; > 5 years), sex, site (infratentorial vs. supratentorial), histology (anaplastic/malignant vs. non-anaplastic/non-malignant), type of resection (complete vs. incomplete); use and fields of RT, and of CT employed were entered in a multivariate regression model to test their impact on OS and PFS. On univariate analysis, radical surgery, the use of RT and age more than 5 years at the time of diagnosis achieved statistically significant values for predicting long-term OS and PFS. Histology reached marginal statistical significance but only for PFS. When those variables were entered in a multivariate analysis only radical resection (P = 0.00142 and 0.0001) resulted a significant factor for predicting long-term OS and PFS, while the use of RT reached a marginal statistical significance, but only for PFS (P = 0.05). Children who had the tumour completely resected did significantly better than all the others who had less than a complete resection, with a 10-year OS and PFS for the two groups of patients of 69.8% (CI 53-86.5%) and 57.2% (CI 40.3-75%) and of 32.5% (CI 8.5-57.6%) and 11.1% (0-24.4%), respectively. These findings suggest that, for childhood EPD, radical resection should be pursued as much as reasonably possible. Thus, it seems justified proposing for future trials, patient stratification by entity of surgical resection.

摘要

本报告的主要目的是呈现对92名年龄小于16岁的室管膜瘤(EPD)患儿进行多因素分析的结果,这些患儿是从意大利七个中心回顾性收集的。他们在16年期间(1977 - 1993年)接受了治疗。治疗方式各不相同。手术和放疗(RT)是这些患儿大多数的“金标准”治疗方法。直到20世纪80年代后期,其中一些患儿才接受化疗(CT),主要使用长春新碱、洛莫司汀(CCNU)和泼尼松。整个研究人群的中位随访时间为36个月(平均43个月;范围12至214个月)。该研究人群的10年总生存率(OS)和无进展生存率(PFS)分别为55.5%(CI 41.4 - 69.4%)和34.7%(CI 21.4 - 47.8%)。年龄(<5岁;>5岁)、性别、部位(幕下与幕上)、组织学(间变性/恶性与非间变性/非恶性)、切除类型(完全切除与不完全切除);RT的使用及照射野,以及所采用的CT均纳入多因素回归模型,以测试它们对OS和PFS的影响。单因素分析显示,根治性手术、RT的使用以及诊断时年龄大于5岁对预测长期OS和PFS具有统计学显著意义。组织学仅对PFS达到边缘统计学意义。当将这些变量纳入多因素分析时,仅根治性切除(P = 0.00142和0.0001)是预测长期OS和PFS的显著因素,而RT的使用仅对PFS达到边缘统计学意义(P = 0.05))。肿瘤完全切除的患儿明显比所有其他切除不完全的患儿情况要好,两组患者的10年OS和PFS分别为69.8%(CI 53 - 86.5%)和57.2%(CI 40.3 - 75%)以及32.5%(CI 8.5 - 57.6%)和11.1%(0 - 24.4%)。这些发现表明,对于儿童EPD,应尽可能合理地进行根治性切除。因此,似乎有理由在未来的试验中根据手术切除程度对患者进行分层。

相似文献

1
Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.对92例室管膜瘤患儿的回顾性分析:意大利儿科神经肿瘤学组
Med Pediatr Oncol. 1997 Aug;29(2):79-85. doi: 10.1002/(sici)1096-911x(199708)29:2<79::aid-mpo3>3.0.co;2-o.
2
Ependymal tumors in childhood.儿童室管膜瘤
Pediatr Blood Cancer. 2005 Sep;45(3):298-303. doi: 10.1002/pbc.20212.
3
Prognostic factors and treatment options for paediatric ependymomas.儿童室管膜瘤的预后因素和治疗选择。
J Clin Neurosci. 2012 Sep;19(9):1228-35. doi: 10.1016/j.jocn.2012.02.006. Epub 2012 Jul 25.
4
Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.幕上脑室外室管膜瘤:一项关注长期预后及预后因素的回顾性研究。
Clin Neurol Neurosurg. 2018 Feb;165:1-6. doi: 10.1016/j.clineuro.2017.12.013. Epub 2017 Dec 13.
5
Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology.小儿幕下室管膜瘤:间变组织学的预后意义。
J Neurooncol. 2012 Feb;106(3):619-26. doi: 10.1007/s11060-011-0699-x. Epub 2011 Aug 24.
6
Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.小儿颅内室管膜瘤的第二项前瞻性AIEOP方案的最终结果。
Neuro Oncol. 2016 Oct;18(10):1451-60. doi: 10.1093/neuonc/now108. Epub 2016 May 18.
7
Prognostic factors in intracranial ependymomas in children.儿童颅内室管膜瘤的预后因素
J Neurosurg. 2000 Oct;93(4):605-13. doi: 10.3171/jns.2000.93.4.0605.
8
Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.重新思考儿童室管膜瘤:回顾性多中心分析显示长期总体生存率较差。
J Neurooncol. 2017 Oct;135(1):201-211. doi: 10.1007/s11060-017-2568-8. Epub 2017 Jul 21.
9
Influence of tumor grade on time to progression after irradiation for localized ependymoma in children.肿瘤分级对儿童局限性室管膜瘤放疗后进展时间的影响。
Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):52-7. doi: 10.1016/s0360-3016(01)02801-2.
10
Childhood intracranial ependymoma: twenty-year experience from a single institution.儿童颅内室管膜瘤:来自单一机构的20年经验。
Cancer. 2007 Jul 15;110(2):432-41. doi: 10.1002/cncr.22782.

引用本文的文献

1
Radiosurgery for central nervous system ependymomas: a systematic review and meta-analysis.中枢神经系统室管膜瘤的放射外科治疗:一项系统评价和荟萃分析。
J Neurooncol. 2025 May 21. doi: 10.1007/s11060-025-05076-z.
2
Conformal Radiation Therapy for Ependymoma at Age ≤3 Years: A 25-Year Experience.≤3 岁室管膜瘤的适形放疗:25 年经验。
Int J Radiat Oncol Biol Phys. 2023 Jul 15;116(4):869-877. doi: 10.1016/j.ijrobp.2023.01.016. Epub 2023 Jan 20.
3
Do We Need Radiotherapy in Grade II Ependymoma?二级室管膜瘤需要放疗吗?
Front Oncol. 2022 Mar 4;12:800505. doi: 10.3389/fonc.2022.800505. eCollection 2022.
4
Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study.评价接受质子治疗的局部颅内室管膜瘤患儿的剂量、体积和预后,该研究为前瞻性 KiProReg 研究。
Neuro Oncol. 2022 Jul 1;24(7):1193-1202. doi: 10.1093/neuonc/noab301.
5
Polish Multi-Institutional Study of Children with Ependymoma-Clinical Practice Outcomes in the Light of Prospective Trials.波兰多机构室管膜瘤患儿研究——基于前瞻性试验的临床实践结果
Diagnostics (Basel). 2021 Dec 14;11(12):2360. doi: 10.3390/diagnostics11122360.
6
An Insight into Pathophysiological Features and Therapeutic Advances on Ependymoma.室管膜瘤的病理生理特征与治疗进展洞察
Cancers (Basel). 2021 Jun 28;13(13):3221. doi: 10.3390/cancers13133221.
7
Supratentorial pediatric cortical ependymomas: a comprehensive retrospective study.幕上小儿皮质室管膜瘤:一项全面的回顾性研究。
Neurosurg Rev. 2021 Jun;44(3):1543-1551. doi: 10.1007/s10143-020-01336-w. Epub 2020 Jun 30.
8
Is H3K27me3 status really a strong prognostic indicator for pediatric posterior fossa ependymomas? A single surgeon, single center experience.H3K27me3状态真的是小儿后颅窝室管膜瘤的一个强有力的预后指标吗?单中心单外科医生的经验。
Childs Nerv Syst. 2020 May;36(5):941-949. doi: 10.1007/s00381-020-04518-5. Epub 2020 Feb 5.
9
Case-based review: ependymomas in adults.基于病例的综述:成人室管膜瘤
Neurooncol Pract. 2018 Aug;5(3):142-153. doi: 10.1093/nop/npy026. Epub 2018 Jul 24.
10
Current and Emerging Methods of Management of Ependymoma.《室管膜瘤的当前和新兴治疗方法》。
Curr Oncol Rep. 2019 Jul 29;21(9):78. doi: 10.1007/s11912-019-0826-y.